Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
4062 ARTÍCULOS , VIENDO DEL 1006 AL 1020
When should orthostatic blood pressure changes be evaluated in elderly: 1st, 3rd or 5th minute?
Soysal P, Aydin AE, Koc Okudur S, Isik AT.
Arch Gerontol Geriatr. 2016 Jul-Aug;65:199-203. doi: 10.1016/j.archger.2016.03.022. Epub 2016 Apr 6.
Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases
Hernando S, Gartziandia O, Herran E, Pedraz JL, Igartua M, Hernandez RM.
Nanomedicine (Lond). 2016 May;11(10):1267-85. doi: 10.2217/nnm-2016-0019. Epub 2016 Apr 14.
Glutathione S-transferase M1 polymorphisms and Parkinson's disease risk: a meta-analysis
Wang D, Zhai JX, Liu DW.
Neurol Res. 2016 Feb;38(2):144-50. doi: 10.1080/01616412.2015.1126996. Epub 2016 Mar 16.
Is it just a coincidence? Three new cases of Myasthenia Gravis associated with Parkinson's disease
Sciacca G, Nicoletti A, Mostile G, Dibilio V, Raciti L, Luca A, Reggio E, Zappia M.
Parkinsonism Relat Disord. 2016 Jul;28:166-8. doi: 10.1016/j.parkreldis.2016.04.005. Epub 2016 Apr 12.
The adaptive deep brain stimulation challenge
Arlotti M, Rosa M, Marceglia S, Barbieri S, Priori A.
Parkinsonism Relat Disord. 2016 Jul;28:12-7. doi: 10.1016/j.parkreldis.2016.03.020. Epub 2016 Apr 2.
The role of electromagnetic fields in neurological disorders
Terzi M, Ozberk B, Deniz OG, Kaplan S.
J Chem Neuroanat. 2016 Sep;75(Pt B):77-84. doi: 10.1016/j.jchemneu.2016.04.003. Epub 2016 Apr 12.
Genetic substrates of psychosis in patients with Parkinson's disease: A critical review
Lenka A, Arumugham SS, Christopher R, Pal PK.
J Neurol Sci. 2016 May 15;364:33-41. doi: 10.1016/j.jns.2016.03.005. Epub 2016 Mar 3.
Reliability and validity of an instrument for the assessment of bradykinesia
Mentzel TQ, Lieverse R, Levens A, Mentzel CL, Tenback DE, Bakker PR, Daanen HAM, van Harten PN.
Psychiatry Res. 2016 Apr 30;238:189-195. doi: 10.1016/j.psychres.2016.02.011. Epub 2016 Feb 17.
Ricciardi L, Espay KJ, Krikorian R, Fasano A, Espay AJ.
Parkinsonism Relat Disord. 2016 Jul;28:152-4. doi: 10.1016/j.parkreldis.2016.03.014. Epub 2016 Mar 22.
Alexithymia in Parkinson's disease: A systematic review of the literature
Assogna F, Cravello L, Orfei MD, Cellupica N, Caltagirone C, Spalletta G.
Parkinsonism Relat Disord. 2016 Jul;28:1-11. doi: 10.1016/j.parkreldis.2016.03.021. Epub 2016 Mar 30.
Neurourologic dysfunction: evaluation, surveillance and therapy
Harris CJ, Lemack GE.
Curr Opin Urol. 2016 Jul;26(4):290-4. doi: 10.1097/MOU.0000000000000290.
Lv X, Wang XX, Hou J, Fang ZZ, Wu JJ, Cao YF, Liu SW, Ge GB, Yang L.
Toxicol Appl Pharmacol. 2016 Jun 15;301:42-9. doi: 10.1016/j.taap.2016.04.009. Epub 2016 Apr 16.
Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease
Besser LM, Litvan I, Monsell SE, Mock C, Weintraub S, Zhou XH, Kukull W.
Parkinsonism Relat Disord. 2016 Jun;27:54-60. doi: 10.1016/j.parkreldis.2016.04.007. Epub 2016 Apr 9.
Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD)
Zhou ZD, Sathiyamoorthy S, Angeles DC, Tan EK.
Mol Brain. 2016 Apr 18;9:41. doi: 10.1186/s13041-016-0218-2.
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease
LeWitt PA, Hauser RA, Grosset DG, Stocchi F, Saint-Hilaire MH, Ellenbogen A, Leinonen M, Hampson NB, DeFeo-Fraulini T, Freed MI, Kieburtz KD.
Mov Disord. 2016 Sep;31(9):1356-65. doi: 10.1002/mds.26611. Epub 2016 Apr 19.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.